Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Study ID
- NCT06711666
- Status
- Recruiting
Conditions
- Congenital Heart Disease
- Cyanotic Congenital Heart Disease
- Hypoplastic Left Heart Syndrome
- d-Transposition of the Great Arteries
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 50 Years
- Healthy Volunteers
- Not accepted
Study Details
Congenital heart disease (CHD) is the leading cause of congenital malformations, representing 1% of live births. Progress in surgical care have led to the dramatic increase in the population of children and adults living with heart disease. As survival is no longer a concern, long-term outcomes have become the major public health issue. Prenatal diagnosis of CHD requiring open-heart surgery can be a traumatic event for expecting mothers and fathers. In the general population, maternal mental health distress is associated with fetal disturbances in the hypothalamic-adrenal-pituitary system axis, restricted intrauterine growth and adverse outcomes in the offspring. It is unknown whether prenatal maternal psychological distress have an impact on neurodevelopmental outcomes in CHD. Our national study seeks to (1) characterize the impact of prenatal maternal psychological distress on neurodevelopmental outcomes at age 1 for children with CHD who undergo neonatal open-heart surgery; (2) investigate the sociodemographic and medical determinants associated with prenatal maternal mental health of women carrying a foetus diagnosed with complex CHD; (3) explore the mediating role of prenatal risk factors (i.e., sociodemographic, medical and maternal coping mechanisms) in the association of prenatal maternal mental health (i.e., distress, anxiety and depression) and neurodevelopment in children with CHD; and (4) explore the impact of paternal or the co-parent's mental health impact on neurodevelopmental outcomes at age 1 in children with CHD. This study is a non-interventional, prospective, and longitudinal study of prenatal maternal mental health and subsequent child's neurodevelopmental and behavioural outcomes. It includes a follow-up period from the 3rd trimester of pregnancy until the child's first year of life. It will include children with a prenatally diagnosed heart defect requiring open-heart surgery within the first weeks of life. Understanding and preventing the neurodevelopmental sequelae of heart disease diagnosed in-utero is a public health priority.
Key Dates
- First listed
- Dec 2, 2024
- Start date
- Jun 27, 2025
- Status verified
- May 2026
- Primary completion
- Oct 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 174 participants (estimated)
Primary Outcome Measure
Global Mental Health Self-questionnaire, The Symptom Checklist-90-Revised SCL-90 R (min score 20 - max score 80) [ Time Frame: Time 1 Prenatal Visit and Time 3 1-year old Visit ]
Central Contacts
- Johanna Calderon, PhD330603830737
Related Studies
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal DevelopmentRecruiting · Emory University · Atlanta, Georgia
- Genetics of Congenital Heart DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio
- MRI and Computational Simulation Cardiology StudyEnrolling By Invitation · Stanford University · Palo Alto, California
- ATrial Tachycardia PAcing Therapy in Congenital HeartRecruiting · Ian Law · Los Angeles, California